Fonar stock leans on its imaging business.

By Christina Vaughn, Background & Management desk. Reviewed on July 3, 2026 at 1:51 p.m. ET.

Fonar Corp (US3444371021) is a US medical-imaging company whose business is built around MRI systems and related imaging services. The stock trades on Nasdaq and gives investors direct exposure to a niche healthcare-equipment model that combines equipment, service, and recurring scan revenue.

Business model first

Fonar's core product is the Upright MRI platform, while its imaging centers provide the service side of the business. That mix matters because equipment sales and installed-base utilization can move differently, which gives the company a more layered revenue profile than a pure device maker.

Market context

With no fresh company disclosure in the available results, the cleaner read is operational rather than event-driven. For US investors, the key anchor is still Nasdaq and the company's small-cap healthcare profile, where trading can be sensitive to changes in imaging demand, reimbursement, and capital spending.

Product focus

The Upright MRI is the product that best defines Fonar. It is designed to image patients in weight-bearing positions, which is the feature that separates the system from standard closed MRI setups.

Stock level

Fonar shares trade on Nasdaq in US dollars. As of July 3, 2026, 1:51 p.m. ET, a live price was not available in the search results used for this article.

This article was generated automatically and technically reviewed before publication. Market prices, analyst data and company information are provided without warranty and may change at short notice. This content is for informational purposes only and is not investment, financial, legal or tax advice. It is not a recommendation to buy or sell any security. Investing in securities involves risk, including the possible loss of principal.